Paris Transplant Group at ASN 2019
GET ON BOARD FOR AN EXCITING JOURNEY:
|
Presentations of the Paris Transplant Group at ASN 2019
Alexandre LoupyThu 7 - Starting at 4:42 PM, Room 151
“Absence of Additional Predictive Ability Value of Preimplantation Biopsies for Long-Term Allograft Outcome” Read abstract Fri 8 - Starting at 10:00 AM, Exhibit hall
“Transplantation : Clinical-Immunosuppression, Adherence, Outcomes” Fri 8 - Starting at 2:30 PM, Room 201
“An Integrated Prediction Score of Allograft Survival” |
Carmen LefaucheurFri 8 - Starting at 3:00 PM, Room 201
“Gene Expression Profiling and Histologic and Noninvasive Biomarkers in Antibody-Mediated Rejection” |
Follow the event on Twitter
with the hashtag #KidneyWk and follow us @ParisTxGroup
Takeaway from ASN 2019
iBox: Prediction system
for risk of kidney allograft loss
Based on data easily available during patient follow-up after a kidney transplant, the tool generates probabilities of graft loss up to 10 years after patient evaluation. Tested on more than 7,500 patients, the predictions of this tool are highly reliable regardless of the health system, the clinical situation, the therapeutic intervention or the treatment of the patient.
|
For cliniciansThe iBox, an integrative, accurate, and readily implementable risk prediction score for kidney allograft failure, has been developed and shows generalisability across centres worldwide and common clinical scenarios.
|
For clinical trialsThe iBox risk prediction score may help to guide the monitoring of patients and further improve the design and development of a valid and early surrogate endpoint for clinical trials.
⏯ Use case: the TRANSFORM study |
ASN 2019: time to take action
BE PART OF THE EFFORT TO PROVIDE TRANSPLANT PATIENTS
WITH PERSONALIZED AND PROGNOSTIC MEDICINE WITH THE IBOX
|